Search

Showing "11155" results for ""

Sexual transmission of HCV found in Swiss HIV-positive gay men

Viral load ‘blips’ on NNRTIs linked to low-level viral replication but not treatment failure

HAART during primary HIV infection restores interferon production

Brazil warns of generic Kaletra unless Abbott halves price within 10 days

Tipranavir receives US marketing approval

Generic efavirenz approved for PEPFAR use but 4 African countries reject US drug standard

Bristol Myers Squibb to cut price of two HIV drugs for children

Proof-of-concept study shows benefits of Kaletra / efavirenz combination

Efavirenz reduces blood statin concentrations

3 million on treatment target unlikely to be met by end of 2005, says WHO

HAART and harvest: antiretroviral therapy and nutrition when food is scarce

Pfizer discontinues capravirine development

Methadone included, tenofovir excluded, from new WHO essential drugs list

Pegylated interferon superior to lamivudine for first line hepatitis B treatment

STI increase continues to slow in UK, but is still much cause for concern

Prolonged treatment breaks safe for those who started HAART with high CD4 cell counts

Manchester’s oldest HIV self-help group faces closure in September

Increased vaginal shedding of HIV in pregnant women infected with subtype C

Receive the latest HIV research and conference news

Showing "11155" results for ""

Sexual transmission of HCV found in Swiss HIV-positive gay men

Viral load ‘blips’ on NNRTIs linked to low-level viral replication but not treatment failure

HAART during primary HIV infection restores interferon production

Brazil warns of generic Kaletra unless Abbott halves price within 10 days

Tipranavir receives US marketing approval

Generic efavirenz approved for PEPFAR use but 4 African countries reject US drug standard

Bristol Myers Squibb to cut price of two HIV drugs for children

Proof-of-concept study shows benefits of Kaletra / efavirenz combination

Efavirenz reduces blood statin concentrations

3 million on treatment target unlikely to be met by end of 2005, says WHO

HAART and harvest: antiretroviral therapy and nutrition when food is scarce

Pfizer discontinues capravirine development

Methadone included, tenofovir excluded, from new WHO essential drugs list

Pegylated interferon superior to lamivudine for first line hepatitis B treatment

STI increase continues to slow in UK, but is still much cause for concern

Prolonged treatment breaks safe for those who started HAART with high CD4 cell counts

Manchester’s oldest HIV self-help group faces closure in September

Increased vaginal shedding of HIV in pregnant women infected with subtype C

Receive the latest HIV research and conference news